SciELO - Scientific Electronic Library Online

 
vol.22 suppl.1An astounding inguinal lump: malignant fibrous histiocytoma of the spermatic cordSeptic shock due to Actinomyces turicensis, associated with cervical cancer. Case report author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Gaceta mexicana de oncología

On-line version ISSN 2565-005XPrint version ISSN 1665-9201

Gac. mex. oncol. vol.22  suppl.1 Ciudad de México Jul. 2023  Epub Sep 11, 2023

https://doi.org/10.24875/j.gamo.23000006 

Clinical cases

Acute abdomen as initial manifestation of intestinal t-type non-Hodgkin lymphoma: case report

Abdomen agudo como manifestación inicial de linfoma intestinal tipo T no Hodgkin: reporte de caso

Paola Sánchez1 

Laura C. Rodríguez2 

Nicolás Bastidas3  * 

1Department of Radiology, Fundación Clínica Shaio, Bogotá

2Department of Radiology, Universidad de la Sabana, Chía, Cundinamarca

3School of Medicine, Universidad de la Sabana, Chía, Cundinamarca. Colombia


Abstract

Enteric T-lymphoma subtype has an incidence of 0.5/1 million inhabitants per year. The most common presentation is Type I that represents 80-90% of cases common in western countries. Type II present in 10-20% of cases, not associated with celiac disease and more frequent in Asian countries according to the WHO classification and was the subtype presented by the case patient which is extremely rare in Western countries and no cases have been described in Colombia. The importance of describing this case is to set a precedent of the existence in our country and to suspect the disease whit a similar clinical.

Keywords T-lymphoma; Enteric lymphoma; Gastrointestinal lymphoma; Acute abdomen

Resumen

El subtipo de linfoma T entérico tiene una incidencia de 0.5 por 1 millón de habitantes por año. La presentación más común es el tipo I, que representa el 80-90% de los casos comunes en los países occidentales. El tipo II, presente en el 10-20% de los casos, no asociado a enfermedad celíaca, es mas frecuente en países asiáticos según la clasificación de la Organización Mundial de la Salud y fue el subtipo presentado por el paciente del caso, que es extremadamente raro en países occidentales y del cual no se han descrito casos en Colombia. La importancia de describir este caso es sentar un precedente de la existencia en nuestro país y sospechar la enfermedad en un paciente con una clínica similar.

Palabras clave Linfoma T; Linfoma entérico; Linfoma gastrointestinal; Abdomen agudo

Introduction

Enteric T-lymphoma subtype represents < 20% of lymphomas of the intestinal tract, with a low annual incidence according to epidemiological data1. Two histological subtypes have been described. Type I with refractory celiac disease that represents 80-90% of cases common in western countries. Type II is present sporadically in 10-20% of cases, not associated with celiac disease and more frequent in Asian countries according to the WHO classification1. Clinically, these patients debut with acute abdomen due to intestinal perforation in more than 50% of cases. A 60% survival rate has been reported when there is no secondary disease and < 20% at 5 years when there is metastatic involvement1. In Colombia, no cases associated with Type 2 have been reported. We describe a patient who presented an exact picture of subtype 2, infrequent in western countries and of which there are no reports in Colombia. The acute manifestation was an acute abdomen after a closed abdominal trauma where the case was oriented based on the imaging findings and the clinic presented to perform the surgical procedure.

Case description

A 53-year-old male patient was admitted to the emergency department due to a 4-day history of abdominal pain in the upper abdomen radiating to the dorsal region, pain which began after receiving blunt trauma with a soccer ball in the epigastrium. Subsequently, he developed nausea and fever and decided to consult for this reason. During the review by systems on admission, he did not report any additional pain, he denied weight loss, diaphoresis, or other constitutional symptoms and he referred that it was the 1st time he presented that clinical picture.

On initial physical examination, he was afebrile, diaphoretic, dehydrated, algic, normotensive, tachycardic, with adequate oximetry, and generalized mucocutaneous pallor. The abdomen was distended, with generalized peristaltic sounds decreased in frequency and intensity, pain on superficial, and deep palpation in the epigastric region and in the right hypochondrium, with a doubtful Murphy’s sign and no signs of peritoneal irritation.

Paraclinical tests do not show leukocytosis or neutrophilia (White blood cells [WBC]: 5700 c/mm3, N: 5.1%, Hemoglobin [HB]: 17.4 g/dL PL: 346,000 c/mm3), arterial gasses with hyperlactatemia (1.87 mmol/L), liver profile in normal ranges (Alanine aminotransferase: 21, Aspartate aminotransferase: 35, Total bilirubin: 1.16, bilirubin Indirect: 0.86, Bilirubin direct: 0.3, Alkaline phosphatase: 65). A total abdominal ultrasound was performed where a moderate amount of free perihepatic, perisplenic, and pelvic fluid was found. He was assessed by the general surgery service who indicated the taking of an abdominal CT due to the suspicion of mesenteric ischemia versus abdominal sepsis. 24 h later, the patient presented hypotension and tachycardia with new paraclinical tests with marked leukocytosis and elevation of acute phase reactants with elevation of nitrogen (WBC: 23,100 c/mm3, N: 91%, HB: 17 g/dL %, PL: 342,000 c/mm3, Polymerase chain reaction: 183 mg/L). The findings found in the tomography showed generalized ascites, diffuse edema of the mesenteric fat, without evidence of organized collections, diffuse thickening of the walls of the ascending colon, and the terminal ileum and bilateral pleural effusions, with passive atelectasis of the adjacent lung segments. Finally after exhaustive review of the intestinal loops, a continuity solution of the jejunal loop was visualized with extralumination of the intestinal content (Fig. 1).

Figure 1 Contrasted abdominal tomography. A and B: Axial, Coronal section of the abdomen with contrast with abundant ascitic fluid. C: Sagittal section of the jejunal loop with loss of continuity of its wall and extralumination of its content. 

Abdominal sepsis was suspected due to visceral perforation, starting antibiotic therapy and subsequently an exploratory laparotomy was performed. During the surgical procedure, ascitic fluid was found, thickening with inflammatory changes of the epiploic appendages and section of the jejunum of 90% of its circumference at 25 cm from the Treitz angle (Fig. 2). Peritoneal fluid drainage, enterotomy with side-to-side anastomosis, and proximal exeresis of the surgical piece were performed, which was carried out for pathological study, reporting non-Hodgkin’s T lymphoma.

Figure 2 Exploratory laparotomy with a cross section of 90% of the jejunal loop at 20 cm from the Treitz angle. 

Discussion

Primary gastrointestinal tumors of the small intestine account for about 2% of all malignancies. Primary gastrointestinal lymphoma (PGIL) is a rare neoplasm that corresponds to 1 to 4% of tumors of the gastrointestinal tract2, made up of only 5-20% of all extranodal lymphomas. The stomach, small intestine, colon, and ileocecal valve are the most affected sites of tumor involvement3-5. In the small intestine, a higher percentage of presentation in the ileum has been described in 60% of cases, followed by the jejunum in approximately 25% and finally the duodenum6.

PGIL is the most frequent extranodal manifestation of non-Hodgkin lymphoma (NHL) representing 20%7 of cases, originating histologically from the lamina propria and submucosa; its main difference from secondary lymphoid tumors, is given by its tendency to develop in multiple locations, including mesenteric nodes due to the abundant lymphoid tissue in the gastrointestinal tract. Histologically, the most frequent NHL is the diffuse type of giant B cells and the mucosa associated lymphoid tissue type8, being T and NK/T cell lymphoma the ones with the worst prognosis and the most infrequent, covering approximately 3% of NHL, being more common in Asia and less frequent in the United States and Western countries9.

In its pathogenesis, a close association has been described with Helicobacter pylori infection, HIV, celiac disease, and the epstein-barr virus (EBV). The way in which EBV enters the cell is unknown; however, it is thought that it possesses identical episomes to those present in tumor cells, indicating that it originates from a single infected cell. Histologically, extensive ischemic necrosis is observed along with “large azurophilic granules” in the cytoplasm of tumor cells, a feature that can also be found in normal natural cytolytic lymphocytes9.

On the other hand, enteric T-lymphoma subtype, which originates from the intraepithelial cells of the intestinal mucosa, representing <20% of lymphomas of the intestinal tract, should be suspected as the first diagnostic possibility. It has a reported incidence of 0.5/1 million inhabitants per year10. Its most frequent location is located at the level of the proximal jejunum and ileum. It is divided into Type I that is associated with refractory celiac disease that represent 80-90% of cases and Type II present sporadically in 10-20% of cases, not associated with celiac disease and more frequent in Asian countries according to the WHO classification10.

Histologically, Type I manifests with large multinucleated lymphoid cellularity with irregular nuclei, similar to anaplastic lymphoma, associated with an inflammatory infiltrate with the presence of histiocytes and eosinophils, which leads to necrosis with subsequent intestinal perforation, molecularly, they are positive for CD3, CD7 and CD103, being negative for CD4, CD5, and variable reactivity CD8,CD3010. Type II manifests as a proliferation of small to medium-sized lymphocytes with no associated inflammatory component and with an expressed immunophenotype of CD3, CD4, CD8, and CD5610.

Clinically, these patients debut with acute abdomen due to intestinal perforation in more than 50% of cases, this being more typical in men and less so in Type B lymphomas, abdominal pain associated with nausea or vomiting and constitutional symptoms such as weight loss and diaphoresis have also been described. A 60% of survival rate has been reported when there is no secondary disease and <20% at 5 years when there is metastatic involvement11.

For image analysis, the use of contrast-enhanced abdominal CT and barium studies is preferred; however, the findings may be non-specific. On tomography, the tumor may affect one or several segments of a small intestinal loop with significant thickening of its wall. Aneurysmal dilatation has also been described as a finding secondary to wall invasion and damage to the myenteric plexus.12 Splenomegaly, lymphadenopathies, and lymphadenopathy contiguous to the tumor site or in the retroperitoneal region have also been described, and intestinal obstruction is present in a lesser proportion. In cases of visceral perforation, free fluid can be observed in the peritoneal cavity associated with the aforementioned signs.13

Conclusion

This case represents a typical picture of this histological subtype of enteric T-lymphoma that is infrequent in Western countries and of which there are no current reports in our country. Knowing the existence of this entity has a direct impact on making a timely diagnosis and guiding decision-making in the medical field, since guided by both the clinic and the images, the best treatment for the patient can be indicated and the definitive diagnosis made by means of biopsy taking.

References

1. Llorente CP, Ebri MP, Abril SA, López EM, Aznar JR, Ortega GG, et al. Perforación intestinal secundaria a linfoma T entérico en un paciente sin intolerancia al gluten. Gastroenterol Hepatol 2016;39:331-4. [ Links ]

2. Gurney KA, Cartwright RA. Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. Hematol J 2002;3:95-104. [ Links ]

3. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252-60. [ Links ]

4. Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L. Gastrointestinal involvement in non?Hodgkin's lymphoma. Cancer 1980;46:215-22. [ Links ]

5. Ghimire P, Wu GY, Zhu L. Primary gastrointestinal lymphoma. World J Gastroenterol 2011;17:697-707. [ Links ]

6. Schottenfeld D, Beebe-Dimmer JL, Vigneau FD. The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol 2009;19:58-69. [ Links ]

7. Vargas-Ávila AL, Hernández-Rosas A, Roldán-Tinoco J, Guzmán-Peña LA, Vargas-Flores J, Campos-Badillo JA, et al. Linfoma no Hodgkin gastrointestinal presentándose como abdomen agudo. Cir Gen 2019;41:208-16. [ Links ]

8. Devaney K, Jaffe ES. The surgical pathology of gastrointestinal Hodgkin's disease. Am J Clin Pathol 1991;95:794-801. [ Links ]

9. Kumar V, Abbas A, Fausto N, Robbins S, Cotran R. Patología Estructural Y Funcional. Barcelona:Elsevier;2015. [ Links ]

10. Bautista-Quach, MA, Ake CD, Chen M, Wang J. Gastrointestinal lymphomas:morphology, immunophenotype and molecular features. J Gastrointest Oncol 2012;3:209-25. [ Links ]

11. Ferreri AJM, Zinzani PL, Govi S, Pileri SA. Enteropathy-associated T-cell lymphoma. Crit Rev Oncol Hematol 2011;79:84-90. [ Links ]

12. Insausti-Jaca N, Hernaiz-Argudo L, Larrazabal-Echevarria E, Guantes-Del Vigo MB, Aperribay-Ulacia M, Pérez-Arroyuelos I. Linfoma:manifestaciones radiológicas de la afectación nodal y extranodal en abdomen. SERAM. 2018;1:1-29. [ Links ]

13. Ghai S, Pattison J, Ghai S, O'Malley ME, Khalili K, Stephens M. Primary gastrointestinal lymphoma:spectrum of imaging findings with pathologic correlation. Radiographics 2007;27:1371-88. [ Links ]

FundingThis research has not received any specific grants from agencies in the public, commercial, or for-profit sectors.

Ethical disclosures

Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data. The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent. The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.

Received: January 23, 2023; Accepted: January 31, 2023

* Correspondence: Nicolás Bastidas E-mail: nicobasgu@hotmail.com

Conflicts of interest

The authors declare that they have no conflicts of interest.

Creative Commons License Sociedad Mexicana de Oncología. Published by Permanyer. This is an open ccess article under the CC BY-NC-ND license